NOT KNOWN FACTUAL STATEMENTS ABOUT PMTA 0 11

In addition it addresses the FDA’s communications Together with the applicant, the retention of information that guidance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer possession of the SE report to a different applicant and Digital submission on the SE report